Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romidepsin and Abraxane in metastatic inflammatory breast cancer
NCT01938833Phase 2Terminated
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Apr 2014
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of romidepsin in inflammatory breast cancer (IBC), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Apr 2014; status: terminated.
02
Drugs
romidepsin
03
Conditions
inflammatory breast cancer (IBC)
Beyond the preview
Go deeper on NCT01938833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01938833.